Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Didac Jerez-Dolz"'
Autor:
M. Urooj Zafar, Jose Javier Bravo-Cordero, Sergi Torramade-Moix, Gines Escolar, Didac Jerez-Dolz, Eli I. Lev, Juan Jose Badimon
Publikováno v:
Platelets, Vol 33, Iss 2, Pp 312-319 (2022)
Stent thrombosis (ST) is a catastrophic event and efforts to reduce its incidence by altering blood-stent interactions are longstanding. A new electret coating technology that produces long-lasting negative charge on stent surface could make them int
Externí odkaz:
https://doaj.org/article/c65184c424a946549c2f4a676f6e38d7
Autor:
Gines Escolar, Didac Jerez-Dolz, Sergi Torramade-Moix, M. Urooj Zafar, Jose Javier Bravo-Cordero, Juan J. Badimon, Eli I. Lev
Publikováno v:
Platelets
Stent thrombosis (ST) is a catastrophic event and efforts to reduce its incidence by altering blood-stent interactions are longstanding. A new electret coating technology that produces long-lasting negative charge on stent surface could make them int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1bbb8f859f19b536d41d199960b1afe
https://doi.org/10.1080/09537104.2021.1912313
https://doi.org/10.1080/09537104.2021.1912313
Autor:
Gines Escolar, Rosa Hernandez, Marta Palomo, M. Urooj Zafar, Juan J. Badimon, Sergi Torramade-Moix, Maribel Diaz-Ricart, Ana Belen Moreno-Castaño, Didac Jerez-Dolz, Irene Lopez-Vilchez
Publikováno v:
Atherosclerosis. 294:17-24
Circulating platelet microparticles (PMP) are the most abundant in bloodstream, are highly procoagulant and contribute to cross-talk with inflammatory cells. The aim of the present study was to investigate the interactions of PMP with platelets and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec262f84b17e68c117ae0c047ecfcb3b
https://doi.org/10.1016/j.atherosclerosis.2019.12.017
https://doi.org/10.1016/j.atherosclerosis.2019.12.017
Autor:
M. Urooj Zafar, Maribel Diaz-Ricart, Javier Zamorano-Leon, Cristóbal Gastó, Didac Jerez-Dolz, Juan J. Badimon, Antonio J. López-Farré, Gines Escolar, Irene Lopez-Vilchez, Victor Navarro
Publikováno v:
Thrombosis and Haemostasis. 117:2312-2321
Background Serotonin reuptake inhibitors (SSRIs) may impair platelet function. Thrombin is a strong platelet agonist causing irreversible aggregation, release of granules' contents, cytoskeletal rearrangement and activation of signalling pathways. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee7da2a645543ba07f0fc79c47841771
https://doi.org/10.1160/th17-04-0288
https://doi.org/10.1160/th17-04-0288